durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
['durva', 'nsclc', 'aegean', 'sclc']
aegean: a phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durva in pts with resectable nsclc met both of its primary endpoints of improved pcr and efs #aacr23 
Medical oncologist / Thoracic & skin tumors unit / Hospital de la Santa Creu i Sant Pau / Instituto Oncológico Dr Rosell